Health News Archive - May 08, 2009
FRIMLEY, England, May 8 /PRNewswire/ -- - Glivec(R) (imatinib) Now Approved in the UK for Post-Surgery Treatment of Patients With KIT (CD117)-Positive Gastrointestinal Stromal Tumours (GIST), who are at Significant Risk of the Cancer Returning After Surgery(1) - Use of Glivec(R) After Surgery Significantly Reduces Risk of Cancer Relapse(2) - If Untreated After Surgery, 50% of patients Will Experience Their Cancer Returning Within Two Years(3,4) Glivec(R) has been approved in the UK for the treatment of patients with the gastrointestinal cancer, KIT (CD117)-positive gastrointestinal stromal tumours (GIST), who have had surgery to remove their cancer and are at significant risk of the cancer returning.(1) Data supporting this new use for Glivec demonstrates that 98% of patients receiving 400mg Glivec daily for a year after surgery to remove their GIST did not experience their tumours returning after 12 months compared to 83% of patients taking placebo.(2) Approxi
NAGOYA, Japan, May 8 /PRNewswire/ -- Dr. Hidenari Tanaka, president and CEO of Menicon Co., Ltd. and president of the Japan Contact Lens Association, was appointed as Singapore's Honorary Consul-General in Nagoya, Japan, by the government of the Republic of Singapore.
SAN JOSE, Calif., May 8 /PRNewswire/ -- Teikoku Pharma USA Inc., the international specialty pharmaceutical company today announced that it has acquired effective May 8, 2009; Minneapolis area based Travanti Pharma Inc., a privately held corporation that designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications delivered to the body.
SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Santarus, Inc. (Nasdaq: SNTS) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst day and investor briefing event "Santarus: What's New?".
WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- Universal Capital Management, Inc.
SEATTLE, May 8 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) announced today the pricing of an underwritten public offering of 10,700,000 shares of its common stock. Deutsche Bank Securities will act as sole manager for the offering.
Recent studies report that women suffering severe premenstrual syndrome (PMS) who take sertraline, more commonly known as Zoloft, for 4 months face higher risks for reoccurrence than women who practice 12 month regiments of the medication.
Food and Drug Administration officials are warning parents to keep prescription testosterone gel far from children due to its serious side effects.
According to a new study, color-coded â€œtraffic lightâ€ food labeling systems are better than percentage daily intake systems in helping consumers identify healthy foods.
Encouraging People to Become Involved During May's "National Brain Tumor Awareness Month" WASHINGTON, May 8 /PRNewswire-USNewswire/ -- This week American Idol David Cook and his family shared the sad news of his brother's death from a brain tumor.